Search Results - "Gregora, E"

Simplified novel prognostic score for real-life older adults with multiple myeloma—registry-based analysis by Radocha, J., Hájek, R., Brožová, L., Pour, L., Špička, I., Minařík, J., Gregora, E., Jungová, A., Jelínek, T., Heindorfer, A., Sýkora, M., Maisnar, V.

“…The main goal was to find a simple prognostic to evaluate overall survival of patients older than 65 years of age with myeloma. Retrospective registry-based…”
Get full text

Bortezomib retreatment is effective in relapsed multiple myeloma patients - real-life clinical practice data by Stork, M, Sevcikova, S, Brozova, L, Spicka, I, Maisnar, V, Minarik, J, Jungova, A, Gregora, E, Velichova, R, Hajek, R, Jelinek, T, Pour, L

“…Nowadays, bortezomib, a proteasome inhibitor, is widely used in treatment of newly diagnosed or relapsed multiple myeloma. The aim of this study was to analyze…”
Get more information

Early Diagnosis of Multiple Myeloma - Project CRAB of Czech Myeloma Group(CMG) by Straub, J, Hajek, R, Scudla, V, Maisnar, V, Gregora, E, Schutzova, M, Adam, Z, Bacovsky, J, Spicka, I

Get full text

High-dose immunosuppressive therapy with PBPC support in the treatment of poor risk multiple sclerosis by Kozák, T, Havrdová, E, Pit'ha, J, Gregora, E, Pytlík, R, Maaloufová, J, Marecková, H, Kobylka, P, Vodvárková, S

“…High-dose immunoablative chemotherapy with autologous haematopoietic cell support might be beneficial in the treatment of intractable forms of MS. We mobilised…”
Get full text

High-dose chemotherapy followed by autologous stem cell transplantation changes prognosis of IgD multiple myeloma by Maisnar, V, Hájek, R, Ščudla, V, Gregora, E, Büchler, T, Tichý, M, Kotouček, P, Kafková, A, Forraiová, L, Minařík, J, Radocha, J, Bláha, V, Malý, J

“…Immunoglobulin D (IgD) multiple myeloma (MM) is a rare plasma cell disorder constituting less than 2% of all MM cases. Survival of patients with IgD MM is…”
Get full text

Low-dose thalidomide regimens in therapy of relapsed or refractory multiple myeloma by Zemanova, M, Scudla, V, Adam, Z, Gregora, E, Pour, L, Minarik, J, Pavlicek, P, Pika, T, Bacovsky, J

“…Thalidomide has been estimated as a useful drug in therapy of refractory or relapsed multiple myeloma. Recently, several studies have shown very good results…”
Get more information

Low molecular weight heparins for thromboprophylaxis during induction chemotherapy in patients with multiple myeloma by Kessler, P, Pour, L, Gregora, E, Zemanova, M, Penka, M, Brejcha, M, Adam, Z, Bacovsky, J, Fenclova, M, Frankova, H, Hausdorf, P, Walterova, L, Heinzova, V, Holikova, M, Krejci, M, Kubackova, K, Langrova, E, Maisnar, V, Meluzinova, I, Stavarova, Y, Straub, J, Scudla, V, Gumulec, J, Ullrychova, J, Hajek, R

“…Patients with multiple myeloma have a high risk of venous thromboembolism (VTE), especially during the induction chemotherapy. The aim of our observational…”
Get more information

Rare presentation of non-Hodgkin lymphoma of the thoracolumbar spine in pregnancy with 7 years' survival by KLEZL, Z, KRBEC, M, GREGORA, E, STRITESKY, J

“…A rare, so far unpublished, case of non-Hodgkin lymphoma in 26-year-old pregnant woman is presented. As X ray examination and other investigations were avoided…”
Get full text

Immunoablative therapy with autologous stem cell transplantation in the treatment of poor risk multiple sclerosis by Kozák, T, Havrdová, E, Pit’ha, J, Gregora, E, Pytlı́k, R, Maaloufová, J, Kobylka, P, Vodvár̆ková, S̆

Get full text

International Staging System required standardization of biochemical laboratory testing in multiple myeloma by Tichý, M, Maisnar, V, Palicka, V, Friedecký, B, Vávrová, J, Novotná, H, Cermáková, Z, Dastych, M, Cechák, P, Vogtová, D, Jarolímková, E, Benáková, H, Hachová, L, Bezdícková, D, Kouril, F, Zábranská, E A, Zenková, J, Slabý, P, Scudla, V, Gregora, E, Spicka, I, Straub, J, Schützova, M, Hájek, R

“…The standardization of biochemical measurement procedures in multiple myeloma is necessary for reliable prognostic stratification of patients in multicentric…”
Get more information

Pharmacokinetics of viral antibodies after administration of intravenous immunoglobulin in patients with chronic lymphocytic leukaemia or multiple myeloma by THÜRMANN, P. A, SONNENBURG, C, VALENTOVA, K, GREGORA, E, FREISCHLÄGER, F, LISSNER, R

“…Intravenous immunoglobulin (IVIG) preparations are derived from human pooled plasma and should fulfil high standards of purity and viral safety. Introduction…”
Get full text

Risk Factors Associated with Development of Extramedullary Disease in Multiple Myeloma by Stork, Martin, Sevcikova, Sabina, Krejci, Marta, Adam, Zdenek, Sandecka, Viera, Maisnar, Vladimir, Radocha, Jakub, Spicka, Ivan, Straub, Jan, Minarik, Jiri, Pika, Tomas, Jungova, Alexandra, Gregora, Evzen, Pavlicek, Petr, Vrabel, David, Jarkovsky, Jiri, Brozova, Lucie, Jelinek, Tomas, Hajek, Roman, Pour, Ludek

“…Background Multiple myeloma (MM) is the second most common hematological malignancy characterized by plasma cell (PC) infiltration of the bone marrow…”
Get full text

Real-world Outcomes of Multiple Myeloma: Retrospective Analysis of the Czech Registry of Monoclonal Gammopathies by Hájek, Roman, Jarkovsky, Jiri, Maisnar, Vladimír, Pour, Ludek, Špička, Ivan, Minařík, Jiri, Gregora, Evžen, Kessler, Petr, Sýkora, Michal, Fraňková, Hana, Campioni, Marco, DeCosta, Lucy, Treur, Maarten, Gonzalez-McQuire, Sebastian, Bouwmeester, Walter

“…The Registry of Monoclonal Gammopathies (RMG) collects long-term data for patients with hematologic malignancies and is one of the largest registries of its…”
Get full text

Adjusted comparison of daratumumab monotherapy versus real-world historical control data from the Czech Republic in heavily pretreated and highly refractory multiple myeloma patients by Jelínek, Tomáš, Maisnar, Vladimír, Pour, Luděk, Špička, Ivan, Minařík, Jiří, Gregora, Evžen, Kessler, Petr, Sýkora, Michal, Fraňková, Hana, Adamová, Dagmar, Wróbel, Marek, Mikula, Peter, Jarkovský, Jiří, Diels, Joris, Gatopoulou, Xenia, Veselá, Šárka, Besson, Hervé, Brožová, Lucie, Ito, Tetsuro, Hájek, Roman

“…Objectives: We conducted an adjusted comparison of progression-free survival (PFS) and overall survival (OS) for daratumumab monotherapy versus standard of…”
Get full text

Simplified novel prognostic score for real-life older adults with multiple myeloma-registry-based analysis by Radocha, J, Hájek, R, Brožová, L, Pour, L, Špička, I, Minařík, J, Gregora, E, Jungová, A, Jelínek, T, Heindorfer, A, Sýkora, M, Maisnar, V

“…The main goal was to find a simple prognostic to evaluate overall survival of patients older than 65 years of age with myeloma. Retrospective registry-based…”
Get full text

Standardized parenteral alanyl-glutamine dipeptide supplementation is not beneficial in autologous transplant patients: a randomized, double-blind, placebo controlled study by PYTLIK, R, BENES, P, PATORKOVA, M, CHOCENSKA, E, GREGORA, E, PROCHAZKA, B, KOZAK, T

“…We conducted a controlled, double-blind study of parenteral glutamine supplementation in an unselected group of consecutive autologous transplant patients…”
Get full text

A291 Project CRAB: A Better Quality of Life Through an Early Diagnosis; Project of the Czech Myeloma Group by Straub, J, Hajek, R, Scudla, V, Maisnar, V, Gregora, E, Schutzova, M, Adam, Z, Bacovsky, J, Lapes, J, Spicka, I

Get full text

A251 Better Efficacy/Toxicity Ratio of Velcade-Based Regimens by Hajek, R, Zahradova, L, Gregora, E, Schutzova, M, Koza, V, Pavlicek, P, Pour, L, Krejci, M, Sandecka, V, Krivanova, A, al Sahmani, M, Kralova, D, Adam, Z

Get full text

Effect of parenteral glutamine on restoration of lymphocyte subpopulations after high-dose chemotherapy and autologous hematopoietic cell transplantation: data from a double-blind randomized study by Pytlík, R, Gregora, E, Benes, P, Kozák, T

“…Within the framework of a randomized double blind study focused on the effect of glutamine on the clinical course of autologous transplantation of peripheral…”
Get more information

Recommendations for early identification of damage to the skeleton by malignant processes, and for early diagnosis of multiple myeloma by Adam, Z, Bednarík, J, Neubauer, J, Chaloupka, R, Fojtík, Z, Vanícek, J, Pour, L, Cermákova, Z, Scudla, V, Maisnar, V, Straub, J, Schützová, M, Gregora, E, Weinreb, M, Stuchlíková, K, Stanícek, J, Hájek, R, Krejcí, M, Vorlícek, J

“…The number of newly diagnosed cases of multiple myeloma in the Czech Republic is about 3-4 per 100 000 persons per year. In the higher age groups, the…”
Get more information